The Balancing Act® Shines Light on Window Film, Life of a Patient at a Rehabilitation Hospital, 2-in-1 Tech
June 17, 2015
HealthSouth, iRULU, Rayno Window Film Inc. Take Centre Stage on June 18 Show on Lifetime®
(POMPANO BEACH, Fla. – June 17, 2015) Award-winning morning show The Balancing Act® will feature some of the hottest names in auto tint for sun safety; plus will feature the fourth installment in the HealthSouth miniseries on inpatient rehabilitation hospitals on Thursday, June 18, at 7:30 a.m. (ET/PT) on Lifetime®. Tune in as The Balancing Act hosts help jump start the day with lively conversations and trusted information to empower a woman’s life. The encore presentation of this show will air on June 25, 2015 on Lifetime.
Don’t miss these featured segments taking center stage on The Balancing Act:
- Achieving Quality Outcomes – with HealthSouth
This Health Matters series continues to look at how inpatient rehabilitation hospitals around the country are providing an important service to patients who have been in an acute-care hospital recovering from an injury or illness, but aren’t ready to go home yet. This segment is the final installment in a four part series that looks at conditions they treat and the types of patients that can benefit from physical rehabilitation such as stroke, amputations, hip fractures to spinal cord injury. Learn about a day in the life of a patient, and hear from one of HeathSouth’s patients and their experiences. Join Dr. Dexanne Clohan, Chief Medical Officer at HealthSouth, and Cheryl Miller, DrOT, National Director of Therapy Operations. HealthSouth is one the nation’s largest providers of post-acute healthcare services in the county. For more information, please visit: http://www.HealthSouth.com
- 2-in-1 Laptop/Tablet – with iRULU® Technology
Join Host Julie Moran and Elizabeth Little who returns to the set to show viewers a 2-in-1 laptop/tablet combination that helps busy women multi-task throughout their day.
- Sun Protection While Driving – with Rayno Window Film, Inc.
According to the Journal of the American Academy of Dermatology, 53-percent of all skin cancers occur on the left, or driver’s side of the body. Sitting in a car for any length of time exposes one to ultraviolet (UV) rays. Window tinting can help. It serves many important functions for drivers, including driving safety, skin protection and even protection of a vehicle’s interior. Quality window tinting can help improve driver vision and driver safety by decreasing glare. Join Rachel Min from Rayno Window Film, a company that has created the world’s first nano carbon ceramic automotive film. Developed with a patented formula that exceeds all other traditional window film performance standards, Rayno’s Phantom Series provides 99.9% UV protection and up to 95% IR rejection. For more information, please visit: http://www.raynofilm.com/
“With our segment, we hope people to start looking at window film in a different way. Window film is not just for cosmetic but actually performs and protects you, your vehicle and properties.” – said Min.
About The Balancing Act®
Entering its 7th season, The Balancing Act continues to empower women in all aspects of their lives. The mission at The Balancing Act is simple – to help today’s modern woman balance it all by bringing them positive solutions to enrich and empower them. Entertaining, educational and trusted by women, viewers can tune in to America’s premier morning show The Balancing Act on weekday mornings Monday through Friday at 7:30 am (ET/PT) on Lifetime television. For additional information or to view a segment visit: www.thebalancingact.com
For more information regarding O2 Media, Branded Entertainment, Product Placement and TV Brand Integration go to: http://o2mediainc.com/Pages/187/Branded-Entertainment
Join the Conversation!
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.